Observational studyBMC pulmonary medicine2022

Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasis.

Michihito Miyagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.